EL7.AI
StocksMedium•16 November 2026•
4 min read

UK Consortium of More Than 20 Companies Bids to Challenge Palantir for NHS Data Platform

Key Facts

1The Drystone consortium, which includes more than 20 companies, announced a bid on 16 November 2026.
2Constellation Software subsidiary IMS Maxims is part of the consortium, alongside companies that previously bid for the platform.
3The Federated Data Platform contract was awarded in 2023 and is valued at £330 million over seven years.
4Real GDP grew 0.7% in the third quarter of 2026, following 0.5% growth in the second quarter.
5Production sector output grew 0.3% in September 2026 compared with the previous month.

A UK consortium of more than 20 companies has announced a bid to compete for the existing contract for the National Health Service’s Federated Data Platform, Dealroom News reported on 16 November 2026. The Drystone Health AI Collaboration includes Constellation Software subsidiary IMS Maxims, alongside VitalHub UK, Voror Health Technologies and Black Pear Software. The consortium is led by Shane Tickell of Temple Black, according to the report. The bid represents an effort by a group of health technology suppliers to compete for the platform currently operated by a Palantir-led consortium. But the report available on the bid does not establish that the consortium won the contract or that a new procurement has already been launched; it says the UK government is expected to begin a new procurement process.

The consortium includes two companies that previously bid for the FDP, Voror Health Technologies and Black Pear Software, as well as Toronto-listed VitalHub UK and IMS Maxims. The lineup brings companies connected to earlier competitions together with other suppliers in a single UK-led bid. The consortium announced its bid on Monday, according to the report published on 16 November. This means the announced development concerns the formation of a consortium and submission of a bid, not the announcement of a competition result or a transfer of platform operations. The report did not specify a timetable for the new procurement or details of the bid evaluation schedule.

The contract for the Federated Data Platform was awarded in 2023 and is valued at £330 million over seven years. It is operated by a group led by Palantir Technologies UK, with Accenture, PwC, NECS and Carnall Farrar, according to the UK Department of Health and Social Care. The department said NHS England awarded the contract on 21 November 2023. The long-term contract places significant financial value at the center of any upcoming competition, but does not by itself set the terms or value of a new tender. The consortium companies’ participation in the bid remains a step in competing for a future opportunity, not a change to the current contract.

Authorities spent £101 million on the platform during the 2024-2025 financial year, according to the Department of Health’s annual report, within the £330 million contract value over seven years. This spending recorded in a single financial year differs from the total contract value, which covers its entire term. The original tender notice estimated the base contract, lasting five years, at up to £360 million, with two 12-month extension options. The notice put the maximum value, including both extensions, at about £480 million and linked the actual value to the level of solution usage. These figures show how published estimates differ according to contract term, extensions and usage, and do not constitute an announcement of the value of a new procurement.

Health and Social Care Secretary Yvette Cooper told the Parliament’s Health and Social Care Committee that a review of the contract was under way and formed part of the process set out in the contract. She added that the government would consider costs, benefits and wider systems, and had detailed plans for different scenarios. Cooper said the Federated Data Platform had delivered “significant benefits” and provided ways to use data in specific health institutions. She also linked the government’s approach to developing sovereign UK artificial intelligence in healthcare. The contract review provides the government context for discussion of future procurement, while her testimony did not report a final decision on whether to launch one or choose an alternative to the current operator.

In separate economic data released on 12 November, the Office for National Statistics estimated real gross domestic product grew 0.7% in the third quarter of 2026, following a 0.5% increase in the second quarter. The ONS attributed most of third-quarter growth to services, which rose 0.9%, particularly services provided to businesses. The production sector also grew 0.1%, while construction contracted 0.7%. These figures measure UK economic performance in the quarter from July to September and are not directly related to the Drystone consortium’s bid or the competition for the platform contract. They provide a picture of economic activity during the period of the announcement, not evidence of a commercial impact from the bid.

On a monthly basis, production sector output rose 0.3% in September 2026 compared with August, according to the ONS estimate. Manufacturing increased 0.7%, while mining and quarrying rose 1.4%. Part of the increase was offset by a 1.7% decline in water supply, sewerage and waste management, and a 0.3% fall in electricity, gas, steam and air conditioning. These rates concern monthly output in September and are not quarterly growth rates; they are separate from the consortium news. The ONS scheduled its next quarterly GDP estimate for 22 December 2026.

Open on chart